Surmodics | SRDX - Net Income


Surmodics reported $-11.54M in Net Income for its fiscal quarter ending in September of 2024.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Align Technology USD 135.76M 79.01M Dec/2025
Anika Therapeutics USD 292K 2.62M Dec/2025
Arrowhead Research USD 30.81M 54.56M Dec/2025
Artivion USD 2.42M 4.07M Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Boston Scientific USD 672M 83M Dec/2025
EDAP TMS EUR -5.01M 586K Sep/2025
Edwards Lifesciences USD 91.2M 199.9M Dec/2025
Haemonetics USD 44.74M 6.06M Dec/2025
Heron Therapeutics USD -2.95M 14.54M Dec/2025
J&J USD 5.12B 36M Dec/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Mesa Laboratories USD -1.68M 5.1M Dec/2024
Nektar Therapeutics USD -37.06M 15.31M Sep/2024
Option Care Health USD 58.5M 6.69M Dec/2025
Stryker USD 849M 10M Dec/2025
Surmodics USD -11.54M 3.99M Sep/2024
Trinity Biotech USD -5.14M 11.82M Sep/2025